Judges’ Special Award

The winner of this award will be selected by the judges and will either be awarded to an individual who deserves national recognition for his or her contribution to improving outcomes for cancer patients in the UK or from among the entries received (irrespective of category) for a project that is judged to have made an outstanding contribution deserving of national recognition and a platform to be shared with the wider cancer community.

QiC Oncology 2016 partner:
Bristol-Myers Squibb
Supported by: